Petros Pharmaceuticals Expands Program for Novel Investigational Non-Invasive Treatment Formulation for Peyronie’s Disease

NEW YORK, Nov. 8, 2021 /PRNewswire/ — Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of…

Alnylam Initiates KARDIA-2 Phase 2 Study of Investigational Zilebesiran (ALN-AGT) in Patients with Inadequately Controlled Hypertension

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced initiation of…

Honey and Diabetes: Can You Eat Honey When You Live with Diabetes?

Humans have been eating and using honey as medicine for thousands of years. The first record…